Hier finden Sie alle Publikationen von und mit Mitarbeitern der Klinik für Frauenheilkunde und Geburtshilfe nach Jahren sortiert. Sie möchten Einblick nehmen in die Publikationen unserer Mitarbeitenden? Unter jedem Kontakt-Eintrag auf den Team-Seiten finden Sie die Übersicht über die einzelnen Publikationen.
* Keilmann L, Beyer S, Meister S, Jegen M, Buschmann C, Schröder L, Keckstein S, Jeschke U, Burges A, Mahner S, Trillsch F, Kost B, Kolben T. Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in Germany. Arch Gynecol Obstet. 2023 Jan;307(1):129-137. doi: 10.1007/s00404-022-06730-x. Epub 2022 Sep 7. PMID: 36068363; PMCID: PMC9449266.
* Liao Y, Badmann S, Kraus F, Topalov NE, Mayr D, Kolben T, Hester A, Beyer S, Mahner S, Jeschke U, Trillsch F, Czogalla B, Burges A. PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer. Int J Mol Sci. 2023 Jan 3;24(1):882. doi: 10.3390/ijms24010882. PMID: 36614323; PMCID: PMC9821466.
* Löb S, Knabl J, Vattai A, Schmoeckel E, Kuhn C, Mittelberger J, Wöckel A, Mahner S, Jeschke U. Obesity in pregnancy is associated with macrophage influx and an upregulated GRO-alpha and IL-6 expression in the decidua. J Reprod Immunol. 2023 Jan 11;156:103800. doi: 10.1016/j.jri.2023.103800. Epub ahead of print. PMID: 36640674
* Köpke MM, Aktas B, Ditsch N. Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023. Curr Opin Obstet Gynecol. 2023 Feb 1;35(1):67-72. doi: 10.1097/GCO.0000000000000835. PMID: 36595649..
* Knabl J, Hüttenbrenner R, Mahner S, Kainer F, Desoye G, Jeschke U. Lower HLA-G levels in extravillous trophoblasts of human term placenta in gestational diabetes mellitus than in normal controls. Histochem Cell Biol. 2022 Dec 20. doi: 10.1007/s00418-022-02163-4. Epub ahead of print. PMID: 36538164.
* Meister S, Dreyer EM, Hahn L, Thomann M, Keilmann L, Beyer S, Mayer C, Prins G, Hasbargen U, Mahner S, Jeschke U, Kolben T, Burges A. Risk of postpartum depressive symptoms is influenced by psychological burden related to the COVID-19 pandemic and dependent of individual stress coping. Arch Gynecol Obstet. 2022 Dec 8:1–12. doi: 10.1007/s00404-022-06854-0. Epub ahead of print. PMID: 36482113; PMCID: PMC9735014.
* Buchholz A, Vattai A, Fürst S, Vilsmaier T, Zati Zehni A, Steger A, Kuhn C, Schmoeckel E, Dannecker C, Mahner S, Jeschke U, Heidegger HH. Prostaglandin E2 receptor EP1 expression in vulvar cancer. J Cancer Res Clin Oncol. 2022 Nov 27. doi: 10.1007/s00432-022-04487-z. Epub ahead of print. PMID: 36436093.
* Köpke MB, Chateau MC, Boissière-Michot F, Schneider M, Garrido F, Zati-Zehni A, Vilsmaier T, Kessler M, Ditsch N, Cavaillès V, Jeschke U. Prognostic Relevance of Nuclear Receptors in Relation to Peritumoral Inflammation and Tumor Infiltration by Lymphocytes in Breast Cancer. Cancers (Basel). 2022 Sep 20;14(19):4561. doi: 10.3390/cancers14194561. PMID: 36230483; PMCID: PMC9559250.
* Kolben T, Mannewitz M, Perleberg C, Schnell K, Anz D, Hahn L, Meister S, Schmoeckel E, Burges A, Czogalla B, Hester A, Mahner S, Kessler M, Jeschke U, Corradini S, Trillsch F, Beyer S. Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells. Cell Oncol (Dordr). 2022 Dec;45(6):1171-1185. doi: 10.1007/s13402-022-00708-2. Epub 2022 Sep 13. PMID: 36098901; PMCID: PMC9747805.
* Beyer S, Müller L, Mitter S, Keilmann L, Meister S, Buschmann C, Kraus F, Topalov NE, Czogalla B, Trillsch F, Burges A, Mahner S, Schmoeckel E, Löb S, Corradini S, Kessler M, Jeschke U, Kolben T. High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer. J Cancer Res Clin Oncol. 2022 Sep 7. doi: 10.1007/s00432-022-04271-z. Epub ahead of print. PMID: 36068443.
* Keilmann L, Beyer S, Meister S, Jegen M, Buschmann C, Schröder L, Keckstein S, Jeschke U, Burges A, Mahner S, Trillsch F, Kost B, Kolben T. Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in Germany. Arch Gynecol Obstet. 2023 Jan;307(1):129-137. doi: 10.1007/s00404-022-06730-x. Epub 2022 Sep 7. PMID: 36068363; PMCID: PMC9449266.
* Löb S, Vattai A, Kuhn C, Mittelberger J, Herbert SL, Wöckel A, Schmoeckel E, Mahner S, Jeschke U. The Pregnancy Zone Protein (PZP) is significantly downregulated in the placenta of preeclampsia and HELLP syndrome patients. J Reprod Immunol. 2022 Sep;153:103663. doi: 10.1016/j.jri.2022.103663. Epub 2022 Jul 9. PMID: 35843132.
* Ma Z, Yang H, Kessler M, Sperandio M, Mahner S, Jeschke U, von Schönfeldt V. Targeting Aberrantly Elevated Sialyl Lewis A as a Potential Therapy for Impaired Endometrial Selection Ability in Unexplained Recurrent Miscarriage. Front Immunol. 2022 Jun 28;13:919193. doi: 10.3389/fimmu.2022.919193. PMID: 35837404; PMCID: PMC9273867.
* Wang Q, Sudan K, Schmoeckel E, Kost BP, Kuhn C, Vattai A, Vilsmaier T, Mahner S, Jeschke U, Heidegger HH. CCL22-Polarized TAMs to M2a Macrophages in Cervical Cancer In Vitro Model. Cells. 2022 Jun 25;11(13):2027. doi: 10.3390/cells11132027. PMID: 35805111; PMCID: PMC9265611.
* Kolben T, Müller L, Meister S, Keilmann L, Buschmann C, Trillsch F, Burges A, Czogalla B, Mitter S, Schmoeckel E, Corradini S, Mahner S, Jeschke U, Kessler M, Beyer S. Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer. J Cancer Res Clin Oncol. 2022 Dec;148(12):3323-3335. doi: 10.1007/s00432-022-04098-8. Epub 2022 Jun 21. PMID: 35729354; PMCID: PMC9587092.
* Lasch M, Sudan K, Paul C, Schulz C, Kolben T, Dorp JV, Eren S, Beyer S, Siniscalchi L, Mahner S, Jeschke U, Meister S. Isolation of Decidual Macrophages and Hofbauer Cells from Term Placenta-Comparison of the Expression of CD163 and CD80. Int J Mol Sci. 2022 May 30;23(11):6113. doi: 10.3390/ijms23116113. PMID: 35682791; PMCID: PMC9181726.
* Hahn L, Meister S, Mannewitz M, Beyer S, Corradini S, Hasbargen U, Mahner S, Jeschke U, Kolben T, Burges A. Gal-2 Increases H3K4me3 and H3K9ac in Trophoblasts and Preeclampsia. Biomolecules. 2022 May 15;12(5):707. doi: 10.3390/biom12050707. PMID: 35625634; PMCID: PMC9139023.
* Pochert N, Schneider M, Ansorge N, Strieder A, Sagasser J, Reiger M, Traidl-Hoffmann C, Neumann A, Jeschke U, Dannecker C, Kühn T, Ditsch N. Seroma after Simple Mastectomy in Breast Cancer-The Role of CD4+ T Helper Cells and the Evidence as a Possible Specific Immune Process. Int J Mol Sci. 2022 Apr 27;23(9):4848. doi: 10.3390/ijms23094848. PMID: 35563236; PMCID: PMC9101279.
* Ansorge N, Dannecker C, Jeschke U, Schmoeckel E, Heidegger HH, Vattai A, Burgmann M, Czogalla B, Mahner S, Fuerst S. Regulatory T Cells with Additional COX-2 Expression Are Independent Negative Prognosticators for Vulvar Cancer Patients. Int J Mol Sci. 2022 Apr 22;23(9):4662. doi: 10.3390/ijms23094662. PMID: 35563052; PMCID: PMC9099805.
* Schrader S, Unverdorben L, Hutter S, Knabl J, Schmoeckel E, Meister S, Zehni AZ, Beyer S, Vilsmaier T, Mahner S, Jeschke U, Kolben T, Buschmann C, Keilmann L. Overexpression of galectin-4 in placentas of women with gestational diabetes. J Reprod Immunol. 2022 Jun;151:103629. doi: 10.1016/j.jri.2022.103629. Epub 2022 Apr 16. PMID: 35468527.
* Shao W, Köpke MB, Vilsmaier T, Zati Zehni A, Kessler M, Sixou S, Schneider M, Ditsch N, Cavaillès V, Jeschke U. Cytoplasmic Colocalization of RXRα and PPARγ as an Independent Negative Prognosticator for Breast Cancer Patients. Cells. 2022 Apr 6;11(7):1244. doi: 10.3390/cells11071244. PMID: 35406808; PMCID: PMC8997589.
* Beyer S, Wehrmann M, Meister S, Kolben TM, Trillsch F, Burges A, Czogalla B, Schmoeckel E, Mahner S, Jeschke U, Kolben T. Galectin-8 and -9 as prognostic factors for cervical cancer. Arch Gynecol Obstet. 2022 Oct;306(4):1211-1220. doi: 10.1007/s00404-022-06449-9. Epub 2022 Apr 4. PMID: 35377045; PMCID: PMC9470666.
* Heublein S, Jeschke U, Sattler C, Kuhn C, Hester A, Czogalla B, Trillsch F, Mahner S, Mayr D, Schmoeckel E, Ditsch N. Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian Cancer. Int J Mol Sci. 2022 Feb 28;23(5):2698. doi: 10.3390/ijms23052698. PMID: 35269838; PMCID: PMC8910424.
* Rogenhofer N, Jeschke U, von Schönfeldt V, Mahner S, Thaler CJ. Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSI. Arch Gynecol Obstet. 2022 Jul;306(1):219-228. doi: 10.1007/s00404-022-06419-1. Epub 2022 Feb 27. PMID: 35220479; PMCID: PMC9300486.
* Mittelberger J, Seefried M, Franitza M, Garrido F, Ditsch N, Jeschke U, Dannecker C. The Role of the Immune Checkpoint Molecules PD-1/PD-L1 and TIM-3/Gal-9 in the Pathogenesis of Preeclampsia-A Narrative Review. Medicina (Kaunas). 2022 Jan 20;58(2):157. doi: 10.3390/medicina58020157. PMID: 35208481; PMCID: PMC8880413.
* Yang H, Kolben T, Kessler M, Meister S, Paul C, van Dorp J, Eren S, Kuhn C, Rahmeh M, Herbst C, Fink SG, Weimer G, Mahner S, Jeschke U, von Schönfeldt V. FAM111A Is a Novel Molecular Marker for Oocyte Aging. Biomedicines. 2022 Jan 25;10(2):257. doi: 10.3390/biomedicines10020257. PMID: 35203468; PMCID: PMC8869572.
* Meister S, Hahn L, Beyer S, Mannewitz M, Perleberg C, Schnell K, Anz D, Corradini S, Schmoeckel E, Mayr D, Hasbargen U, Zati Zehni A, Mahner S, Jeschke U, Kolben T. Regulatory T Cell Apoptosis during Preeclampsia May Be Prevented by Gal-2. Int J Mol Sci. 2022 Feb 7;23(3):1880. doi: 10.3390/ijms23031880. PMID: 35163802; PMCID: PMC8836599.
* Ye Y, Peng L, Chelariu-Raicu A, Kuhn C, Dong X, Jeschke U, von Schönfeldt V. Prostaglandin E2 receptor 3 promotes M1 macrophages polarization in unexplained recurrent pregnancy loss. Biol Reprod. 2022 May 17;106(5):910-918. doi: 10.1093/biolre/ioac030. PMID: 35134851.
* Badmann S, Mayr D, Schmoeckel E, Hester A, Buschmann C, Beyer S, Kolben T, Kraus F, Chelariu-Raicu A, Burges A, Mahner S, Jeschke U, Trillsch F, Czogalla B. AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin. Sci Rep. 2022 Feb 3;12(1):1862. doi: 10.1038/s41598-022-05785-9. PMID: 35115586; PMCID: PMC8814148.
* Keckstein S, Tilgener C, Jeschke U, Hofmann S, Vilsmaier T, Kaltofen T, Heidegger H, Batz F, Mahner S, Schröder L. Effects of matcha tea extract on cell viability and peroxisome proliferator-activated receptor γ expression on T47D breast cancer cells. Arch Gynecol Obstet. 2022 Aug;306(2):451-459. doi: 10.1007/s00404-021-06381-4. Epub 2022 Jan 25. PMID: 35079875; PMCID: PMC9349150.
* Meister S, Kellner I, Beyer S, Corradini S, Schulz C, Rogenhofer N, Keilmann L, Kolben TM, Mahner S, Kessler M, Jeschke U, Kolben T. Epigenetic changes occur in placentas of spontaneous and recurrent miscarriages. J Reprod Immunol. 2022 Feb;149:103466. doi: 10.1016/j.jri.2021.103466. Epub 2021 Dec 14. PMID: 34929495.
* Chen F, Kolben T, Meister S, Czogalla B, Kolben TM, Hester A, Burges A, Trillsch F, Schmoeckel E, Mayr D, Mayerhofer A, Mahner S, Jeschke U, Beyer S. The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer. Arch Gynecol Obstet. 2022 Jun;305(6):1559-1572. doi: 10.1007/s00404-021-06262-w. Epub 2021 Dec 6. PMID: 34870752; PMCID: PMC9166836.
* Vattai A, Kremer N, Meister S, Beyer S, Keilmann L, Hester A, Temelkov M, Heidegger H, Schmoeckel E, Kessler M, Mahner S, Jeschke U, Hertlein L, Kolben T. Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia. J Cancer Res Clin Oncol. 2022 Feb;148(2):377-386. doi: 10.1007/s00432-021-03838-6. Epub 2021 Nov 5. PMID: 34739585.
* Karsten N, Kolben T, Mahner S, Beyer S, Meister S, Kuhn C, Schmoeckel E, Wuerstlein R, Harbeck N, Ditsch N, Jeschke U, Friese K, Kolben TM. The role of E-Cadherin expression in primary site of breast cancer. Arch Gynecol Obstet. 2022 Apr;305(4):913-920. doi: 10.1007/s00404-021-06198-1. Epub 2021 Sep 12. PMID: 34510244; PMCID: PMC8967771.
* Chen F, Novák Z, Dannecker C, Mokráš C, Sui L, Zhang Y, You Z, Han L, Lang J, Hillemanns P. Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol. BMJ Open. 2022 Jun 6;12(6):e061740. doi: 10.1136/bmjopen-2022-061740. PMID: 35667715; PMCID: PMC9171256.
* Fehm T, Stübs FA, Koch MC, Mallmann P, Dannecker C, Dietl A, Sevnina A, Mergel F, Lotz L; Carolin C.Hack; Ehret A, Gantert D, Martignoni F, Cieslik JP, Menke J, Ortmann O, Stromberger C, Oechsle K, Hornemann B, Mumm F, Grimm C, Sturdza A, Wight E, Loessl K, Golatta M, Hagen V, Dauelsberg T, Diel I, Münstedt K, Merz E, Vordermark D, Lindel K, Wittekind C, Küppers V, Lellé R, Neis K, Griesser H, Pöschel B, Steiner M, Freitag U, Gilster T, Schmittel A, Friedrich M, Haase H, Gebhardt M, Kiesel L, Reinhardt M, Kreißl M, Kloke M, Horn LC, Wiedemann R, Marnitz S, Letsch A, Zraik I, Mangold B, Möckel J, Alt C, Wimberger P, Hillemanns P, Paradies K, Mustea A, Denschlag D, Henscher U, Tholen R, Wesselmann S, Beckmann MW. Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities. Geburtshilfe Frauenheilkd. 2022 Feb 11;82(2):181-205. doi: 10.1055/a-1671-2446. PMID: 35197803; PMCID: PMC8855983.
* Beckmann MW, Stübs FA, Koch MC, Mallmann P, Dannecker C, Dietl A, Sevnina A, Mergel F, Lotz L, Hack CC, Ehret A, Gantert D, Martignoni F, Cieslik JP, Menke J, Ortmann O, Stromberger C, Oechsle K, Hornemann B, Mumm F, Grimm C, Sturdza A, Wight E, Loessl K, Golatta M, Hagen V, Dauelsberg T, Diel I, Münstedt K, Merz E, Vordermark D, Lindel K, Wittekind C, Küppers V, Lellé R, Neis K, Griesser H, Pöschel B, Steiner M, Freitag U, Gilster T, Schmittel A, Friedrich M, Haase H, Gebhardt M, Kiesel L, Reinhardt M, Kreißl M, Kloke M, Horn LC, Wiedemann R, Marnitz S, Letsch A, Zraik I, Mangold B, Möckel J, Alt C, Wimberger P, Hillemanns P, Paradies K, Mustea A, Denschlag D, Henscher U, Tholen R, Wesselmann S, Fehm T. Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy. Geburtshilfe Frauenheilkd. 2022 Feb 11;82(2):139-180. doi: 10.1055/a-1671-2158. PMID: 35169387; PMCID: PMC8837407.
* Woelber L, Hampl M, Eulenburg CZ, Prieske K, Hambrecht J, Fuerst S, Klapdor R, Heublein S, Gass P, Rohner A, Canzler U, Becker S, Bommert M, Bauerschlag D, Denecke A, Hanker L, Runnebaumn I, Forner DM, Schochter F, Klar M, Schwab R, Koepke M, Kalder M, Hantschmann P, Ratiu D, Denschlag D, Schroeder W, Tuschy B, Baumann K, Mustea A, Soergel P, Bronger H, Bauerschmitz G, Kosse J, Koch MC, Ignatov A, Sehouli J, Dannecker C, Mahner S, Jaeger A. Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study. Cancers (Basel). 2022 Jan 14;14(2):418. doi: 10.3390/cancers14020418. PMID: 35053582; PMCID: PMC8773532.
* Banys-Paluchowski M, Untch M, Krawczyk N, Thurmann M, Kühn T, Sehouli J, Gasparri ML, de Boniface J, Gentilini OD, Stickeler E, Ditsch N, Rody A, Paluchowski P, Blohmer JU. Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey. Arch Gynecol Obstet. 2022 Oct 10. doi: 10.1007/s00404-022-06804-w. Epub ahead of print. PMID: 36214890.
* Banys-Paluchowski M, Thill M, Kühn T, Ditsch N, Heil J, Wöckel A, Fallenberg E, Friedrich M, Kümmel S, Müller V, Janni W, Albert US, Bauerfeind I, Blohmer JU, Budach W, Dall P, Fasching P, Fehm T, Gluz O, Harbeck N, Huober J, Jackisch C, Kolberg-Liedtke C, Kreipe HH, Krug D, Loibl S, Lüftner D, Lux MP, Maass N, Mundhenke C, Nitz U, Park-Simon TW, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Untch M, Witzel I, Gerber B. AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022. Geburtshilfe Frauenheilkd. 2022 Sep 30;82(10):1031-1043. doi: 10.1055/a-1904-6231. PMID: 36186147; PMCID: PMC9525149.
* Ditsch N, Wöcke A, Untch M, Jackisch C, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, Budach W, Dall P, Fallenberg EM, Fasching PA, Fehm TN, Friedrich M, Gerber B, Gluz O, Harbeck N, Heil J, Huober J, Kreipe HH, Krug D, Kühn T, Kümmel S, Kolberg-Liedtke C, Loibl S, Lüftner D, Lux MP, Maass N, Mundhenke C, Nitz U, Park-Simon TW, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Witzel I, Müller V, Janni W, Thill M. AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022. Breast Care (Basel). 2022 Aug;17(4):403-420. doi: 10.1159/000524879. Epub 2022 May 5. PMID: 36156915; PMCID: PMC9453658.
* Thill M, Lüftner D, Kolberg-Liedtke C, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, Budach W, Dall P, Fallenberg EM, Fasching PA, Fehm T, Friedrich M, Gerber B, Gluz O, Harbeck N, Heil J, Huober J, Jackisch C, Kreipe HH, Krug D, Kühn T, Kümmel S, Loibl S, Lux M, Maass N, Mundhenke C, Nitz U, Park-Simon TW, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Untch M, Witzel I, Wöckel A, Müller V, Janni W, Ditsch N. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022. Breast Care (Basel). 2022 Aug;17(4):421-429. doi: 10.1159/000524789. Epub 2022 May 2. PMID: 36156913; PMCID: PMC9453659.
* Fehm TN, Welslau M, Müller V, Lüftner D, Schütz F, Fasching PA, Janni W, Thomssen C, Witzel I, Belleville E, Untch M, Thill M, Tesch H, Ditsch N, Lux MP, Aktas B, Banys-Paluchowski M, Schneeweiss A, Kolberg-Liedtke C, Hartkopf AD, Wöckel A, Kolberg HC, Harbeck N, Stickeler E. Update Breast Cancer 2022 Part 3 - Early-Stage Breast Cancer. Geburtshilfe Frauenheilkd. 2022 Sep 13;82(9):912-921. doi: 10.1055/a-1912-7105. PMID: 36110894; PMCID: PMC9470293.
* Aktas B, Fehm TN, Welslau M, Müller V, Lüftner D, Schütz F, Fasching PA, Janni W, Thomssen C, Witzel I, Belleville E, Untch M, Thill M, Tesch H, Ditsch N, Lux MP, Banys-Paluchowski M, Kolberg-Liedtke C, Hartkopf AD, Wöckel A, Kolberg HC, Stickeler E, Harbeck N, Schneeweiss A. Update Breast Cancer 2022 Part 4 - Advanced-Stage Breast Cancer. Geburtshilfe Frauenheilkd. 2022 Sep 13;82(9):922-931. doi: 10.1055/a-1912-7362. PMID: 36110891; PMCID: PMC9470282.
* Welslau M, Müller V, Lüftner D, Schütz F, Stickeler E, Fasching PA, Janni W, Thomssen C, Witzel I, Fehm TN, Belleville E, Bader S, Seitz K, Untch M, Thill M, Tesch H, Ditsch N, Lux MP, Aktas B, Banys-Paluchowski M, Schneeweiss A, Harbeck N, Würstlein R, Hartkopf AD, Wöckel A, Seliger B, Massa C, Kolberg HC. Update Breast Cancer 2022 Part 1 - Early Stage Breast Cancer. Geburtshilfe Frauenheilkd. 2022 Jun 3;82(6):580-589. doi: 10.1055/a-1811-6106. PMID: 35903719; PMCID: PMC9315400.
* Müller V, Welslau M, Lüftner D, Schütz F, Stickeler E, Fasching PA, Janni W, Thomssen C, Witzel I, Fehm TN, Belleville E, Bader S, Seitz K, Untch M, Thill M, Tesch H, Ditsch N, Lux MP, Aktas B, Banys-Paluchowski M, Schneeweiss A, Harbeck N, Würstlein R, Hartkopf AD, Kolberg HC, Wöckel A. Update Breast Cancer 2022 Part 2 - Advanced Stage Breast Cancer. Geburtshilfe Frauenheilkd. 2022 Jun 3;82(6):590-600. doi: 10.1055/a-1811-6148. PMID: 35903715; PMCID: PMC9315399.
* Rhiem K, Auber B, Briest S, Dikow N, Ditsch N, Dragicevic N, Grill S, Hahnen E, Horvath J, Jaeger B, Kast K, Kiechle M, Leinert E, Morlot S, Püsken M, Schäfer D, Schott S, Schroeder C, Siebers-Renelt U, Solbach C, Weber-Lassalle N, Witzel I, Zeder-Göß C, Schmutzler RK. Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer. Breast Care (Basel). 2022 Apr;17(2):199-207. doi: 10.1159/000516376. Epub 2021 Jul 19. PMID: 35702495; PMCID: PMC9149395.
* Lüftner D, Schütz F, Stickeler E, Fasching PA, Janni W, Kolberg-Liedtke C, Kolberg HC, Thomssen C, Müller V, Fehm TN, Belleville E, Bader S, Untch M, Welslau M, Thill M, Tesch H, Ditsch N, Lux MP, Wöckel A, Aktas B, Schneeweiss A, Würstlein R, Hartkopf AD. Correction: Update Breast Cancer 2021 Part 5 - Advanced Breast Cancer. Geburtshilfe Frauenheilkd. 2022 Mar 11;82(2):e1. doi: 10.1055/a-1784-9971. Erratum for: Geburtshilfe Frauenheilkd. 2022 Feb 11;82(2):215-225. PMID: 35283689; PMCID: PMC8916847.
* Lüftner D, Schütz F, Stickeler E, Fasching PA, Janni W, Kolberg-Liedtke C, Kolberg HC, Thomssen C, Müller V, Fehm TN, Belleville E, Bader S, Untch M, Welslau M, Thill M, Tesch H, Ditsch N, Lux MP, Wöckel A, Aktas B, Schneeweiss A, Würstlein R, Hartkopf AD. Update Breast Cancer 2021 Part 5 - Advanced Breast Cancer. Geburtshilfe Frauenheilkd. 2022 Feb 11;82(2):215-225. doi: 10.1055/a-1724-9569. Erratum in: Geburtshilfe Frauenheilkd. 2022 Mar 11;82(2):e1. PMID: 35169389; PMCID: PMC8837406.
* Thomssen C, Fehm TN, Stickeler E, Fasching PA, Janni W, Kolberg-Liedtke C, Kolberg HC, Lüftner D, Müller V, Schütz F, Belleville E, Bader S, Untch M, Welslau M, Thill M, Hartkopf AD, Tesch H, Ditsch N, Lux MP, Wöckel A, Aktas B, Schneeweiss A, Würstlein R. Update Breast Cancer 2021 Part 4 - Prevention and Early Stages. Geburtshilfe Frauenheilkd. 2022 Feb 11;82(2):206-214. doi: 10.1055/a-1724-9639. PMID: 35169388; PMCID: PMC8837401.
* Heil J, Pfob A, Sinn HP, Rauch G, Bach P, Thomas B, Schaefgen B, Kuemmel S, Reimer T, Hahn M, Thill M, Blohmer JU, Hackmann J, Malter W, Bekes I, Friedrichs K, Wojcinski S, Joos S, Paepke S, Ditsch N, Rody A, Große R, van Mackelenbergh M, Reinisch M, Karsten M, Golatta M; RESPONDER Investigators. Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03. Ann Surg. 2022 Mar 1;275(3):576-581. doi: 10.1097/SLA.0000000000004246. PMID: 32657944.
* Schaal NK, Zöllkau J, Hepp P, Fehm T, Hagenbeck C. Pregnant and breastfeeding women's attitudes and fears regarding the COVID-19 vaccination. Arch Gynecol Obstet. 2022 Aug;306(2):365-372. doi: 10.1007/s00404-021-06297-z. Epub 2021 Oct 27. PMID: 34705115; PMCID: PMC8548352.
* Heigl K, Zamfir M, Adler AC, Dammeyer A, Schomacher L, Karlin B, Franitza M, Hörmansdorfer S, Tuschak C, Valenza G, Ochmann U, Herr C, Heinze S. Prevalence of methicillin-sensitive, methicillin-resistant Staphylococcus aureus, and extended-spectrum beta-lactamase-producing Escherichia coli in newborns: a cross-sectional study. J Matern Fetal Neonatal Med. 2022 Nov;35(22):4243-4249. doi: 10.1080/14767058.2020.1849100. Epub 2020 Nov 18. PMID: 33207996.
* Menkhorst E, Than NG, Jeschke U, Barrientos G, Szereday L, Dveksler G, Blois SM. Medawar's PostEra: Galectins Emerged as Key Players During Fetal-Maternal Glycoimmune Adaptation. Front Immunol. 2021 Dec 15;12:784473. doi: 10.3389/fimmu.2021.784473. PMID: 34975875; PMCID: PMC8715898.
* Yang H, Kolben T, Meister S, Paul C, van Dorp J, Eren S, Kuhn C, Rahmeh M, Mahner S, Jeschke U, von Schönfeldt V. Factors Influencing the In Vitro Maturation (IVM) of Human Oocyte. Biomedicines. 2021 Dec 14;9(12):1904. doi: 10.3390/biomedicines9121904. PMID: 34944731; PMCID: PMC8698296.
* Meister S, Kellner I, Beyer S, Corradini S, Schulz C, Rogenhofer N, Keilmann L, Kolben TM, Mahner S, Kessler M, Jeschke U, Kolben T. Epigenetic changes occur in placentas of spontaneous and recurrent miscarriages. J Reprod Immunol. 2022 Feb;149:103466. doi: 10.1016/j.jri.2021.103466. Epub 2021 Dec 14. PMID: 34929495.
* Chen F, Kolben T, Meister S, Czogalla B, Kolben TM, Hester A, Burges A, Trillsch F, Schmoeckel E, Mayr D, Mayerhofer A, Mahner S, Jeschke U, Beyer S. The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer. Arch Gynecol Obstet. 2022 Jun;305(6):1559-1572. doi: 10.1007/s00404-021-06262-w. Epub 2021 Dec 6. PMID: 34870752; PMCID: PMC9166836.
* Garrido F, Wild CM, Mittelberger J, Dobler F, Schneider M, Ansorge N, Köpke M, Strieder A, Ditsch N, Jeschke U, Dannecker C. The Role of Chemokines in Cervical Cancers. Medicina (Kaunas). 2021 Oct 21;57(11):1141. doi: 10.3390/medicina57111141. PMID: 34833360; PMCID: PMC8619382.
* Meister S, Hahn L, Beyer S, Paul C, Mitter S, Kuhn C, von Schönfeldt V, Corradini S, Sudan K, Schulz C, Kolben TM, Mahner S, Jeschke U, Kolben T. Regulation of Epigenetic Modifications in the Placenta during Preeclampsia: PPARγ Influences H3K4me3 and H3K9ac in Extravillous Trophoblast Cells. Int J Mol Sci. 2021 Nov 18;22(22):12469. doi: 10.3390/ijms222212469. PMID: 34830351; PMCID: PMC8622744.
* Vattai A, Kremer N, Meister S, Beyer S, Keilmann L, Hester A, Temelkov M, Heidegger H, Schmoeckel E, Kessler M, Mahner S, Jeschke U, Hertlein L, Kolben T. Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia. J Cancer Res Clin Oncol. 2022 Feb;148(2):377-386. doi: 10.1007/s00432-021-03838-6. Epub 2021 Nov 5. PMID: 34739585.
* Topalov NE, Mayr D, Scherer C, Chelariu-Raicu A, Beyer S, Hester A, Kraus F, Zheng M, Kaltofen T, Kolben T, Burges A, Mahner S, Trillsch F, Jeschke U, Czogalla B. Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer. Front Oncol. 2021 Sep 23;11:713026. doi: 10.3389/fonc.2021.713026. PMID: 34631538; PMCID: PMC8495414.
* Löb S, Ochmann B, Ma Z, Vilsmaier T, Kuhn C, Schmoeckel E, Herbert SL, Kolben T, Wöckel A, Mahner S, Jeschke U. The role of Interleukin-18 in recurrent early pregnancy loss. J Reprod Immunol. 2021 Nov;148:103432. doi: 10.1016/j.jri.2021.103432. Epub 2021 Oct 5. PMID: 34627076.
* Deuster E, Hysenaj I, Kahaly M, Schmoeckel E, Mayr D, Beyer S, Kolben T, Hester A, Kraus F, Chelariu-Raicu A, Burges A, Mahner S, Jeschke U, Trillsch F, Czogalla B. The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine. Cells. 2021 Sep 7;10(9):2337. doi: 10.3390/cells10092337. PMID: 34571986; PMCID: PMC8466210.
* Karsten N, Kolben T, Mahner S, Beyer S, Meister S, Kuhn C, Schmoeckel E, Wuerstlein R, Harbeck N, Ditsch N, Jeschke U, Friese K, Kolben TM. The role of E-Cadherin expression in primary site of breast cancer. Arch Gynecol Obstet. 2022 Apr;305(4):913-920. doi: 10.1007/s00404-021-06198-1. Epub 2021 Sep 12. PMID: 34510244; PMCID: PMC8967771.
* Peng L, Chelariu-Raicu A, Ye Y, Ma Z, Yang H, Ishikawa-Ankerhold H, Rahmeh M, Mahner S, Jeschke U, von Schönfeldt V. Prostaglandin E2 Receptor 4 (EP4) Affects Trophoblast Functions via Activating the cAMP-PKA-pCREB Signaling Pathway at the Maternal-Fetal Interface in Unexplained Recurrent Miscarriage. Int J Mol Sci. 2021 Aug 24;22(17):9134. doi: 10.3390/ijms22179134. PMID: 34502044; PMCID: PMC8430623.
*Yang H, Ma Z, Peng L, Kuhn C, Rahmeh M, Mahner S, Jeschke U, von Schönfeldt V. Comparison of Histone H3K4me3 between IVF and ICSI Technologies and between Boy and Girl Offspring. Int J Mol Sci. 2021 Aug 9;22(16):8574. doi: 10.3390/ijms22168574. PMID: 34445278; PMCID: PMC8395251.
* Vogelsang TLR, Vattai A, Schmoeckel E, Kaltofen T, Chelariu-Raicu A, Zheng M, Mahner S, Mayr D, Jeschke U, Trillsch F. Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer. Int J Mol Sci. 2021 Aug 6;22(16):8479. doi: 10.3390/ijms22168479. PMID: 34445181; PMCID: PMC8395182.
* Bauer TL, Collmar K, Kaltofen T, Loeffler AK, Decker L, Mueller J, Pinter S, Eisler SA, Mahner S, Fraungruber P, Kommoss S, Staebler A, Francis L, Conlan RS, Zuber J, Jeschke U, Trillsch F, Rathert P. Functional Analysis of Non-Genetic Resistance to Platinum in Epithelial Ovarian Cancer Reveals a Role for the MBD3-NuRD Complex in Resistance Development. Cancers (Basel). 2021 Jul 28;13(15):3801. doi: 10.3390/cancers13153801. PMID: 34359703; PMCID: PMC8345099.
* Zati Zehni A, Batz F, Cavaillès V, Sixou S, Kaltofen T, Keckstein S, Heidegger HH, Ditsch N, Mahner S, Jeschke U, Vilsmaier T. Cytoplasmic Localization of RXRα Determines Outcome in Breast Cancer. Cancers (Basel). 2021 Jul 26;13(15):3756. doi: 10.3390/cancers13153756. PMID: 34359656; PMCID: PMC8345077.
* Zheng M, Long J, Chelariu-Raicu A, Mullikin H, Vilsmaier T, Vattai A, Heidegger HH, Batz F, Keckstein S, Jeschke U, Trillsch F, Mahner S, Kaltofen T. Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer. Cancers (Basel). 2021 Jul 3;13(13):3343. doi: 10.3390/cancers13133343. PMID: 34283076; PMCID: PMC8268985.
* Shao W, Kuhn C, Mayr D, Ditsch N, Kailuwait M, Wolf V, Harbeck N, Mahner S, Jeschke U, Cavaillès V, Sixou S. Correction to: Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer. J Cancer Res Clin Oncol. 2021 Sep;147(9):2545-2546. doi: 10.1007/s00432-021-03736-x. Erratum for: J Cancer Res Clin Oncol. 2021 Sep;147(9):2535-2544. PMID: 34269882; PMCID: PMC8587370.
* Liao Y, Badmann S, Kaltofen T, Mayr D, Schmoeckel E, Deuster E, Mannewitz M, Landgrebe S, Kolben T, Hester A, Beyer S, Burges A, Mahner S, Jeschke U, Trillsch F, Czogalla B. Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway. Biomedicines. 2021 Jun 22;9(7):706. doi: 10.3390/biomedicines9070706. PMID: 34206491; PMCID: PMC8301368.
* De Pascali F, Casarini L, Kuhn C, Simoni M, Mahner S, Jeschke U, von Schönfeldt V. Nuclear expression of VDR and AHR is mutually exclusive in glandular cells in endometriosis. Histochem Cell Biol. 2021 Oct;156(4):391-399. doi: 10.1007/s00418-021-02005-9. Epub 2021 Jun 21. PMID: 34155552; PMCID: PMC8550147.
* Ma Z, Yang H, Peng L, Kuhn C, Chelariu-Raicu A, Mahner S, Jeschke U, von Schönfeldt V. Expression of the Carbohydrate Lewis Antigen, Sialyl Lewis A, Sialyl Lewis X, Lewis X, and Lewis Y in the Placental Villi of Patients With Unexplained Miscarriages. Front Immunol. 2021 May 31;12:679424. doi: 10.3389/fimmu.2021.679424. PMID: 34135905; PMCID: PMC8202085.
* Shao W, Kuhn C, Mayr D, Ditsch N, Kailuwait M, Wolf V, Harbeck N, Mahner S, Jeschke U, Cavaillès V, Sixou S. Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer. J Cancer Res Clin Oncol. 2021 Sep;147(9):2535-2544. doi: 10.1007/s00432-021-03670-y. Epub 2021 Jun 3. Erratum in: J Cancer Res Clin Oncol. 2021 Jul 16;: PMID: 34085098; PMCID: PMC8310839.
* Vilsmaier T, Amann N, Löb S, Schmoeckel E, Kuhn C, Zati Zehni A, Meister S, Beyer S, Kolben TM, Becker J, Mumm JN, Mahner S, Jeschke U, Kolben T. The decidual expression of Interleukin-7 is upregulated in early pregnancy loss. Am J Reprod Immunol. 2021 Sep;86(3):e13437. doi: 10.1111/aji.13437. Epub 2021 May 29. PMID: 33934432.
* Beilner D, Kuhn C, Kost BP, Vilsmaier T, Vattai A, Kaltofen T, Mahner S, Schmoeckel E, Dannecker C, Jückstock J, Mayr D, Jeschke U, Heidegger HH. Nuclear receptor corepressor (NCoR) is a positive prognosticator for cervical cancer. Arch Gynecol Obstet. 2021 Nov;304(5):1307-1314. doi: 10.1007/s00404-021-06053-3. Epub 2021 Apr 16. PMID: 33861372; PMCID: PMC8490237.
* Lin L, Kuhn C, Ditsch N, Kolben T, Czogalla B, Beyer S, Trillsch F, Schmoeckel E, Mayr D, Mahner S, Jeschke U, Hester A. Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs). Breast Cancer Res. 2021 Apr 13;23(1):45. doi: 10.1186/s13058-021-01422-x. PMID: 33849622; PMCID: PMC8042723.
* Buchholz A, Vattai A, Fürst S, Vilsmaier T, Kuhn C, Schmoeckel E, Mayr D, Dannecker C, Mahner S, Jeschke U, Heidegger HH. EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer. Cancers (Basel). 2021 Mar 19;13(6):1410. doi: 10.3390/cancers13061410. PMID: 33808776; PMCID: PMC8003514.
* Ansorge N, Dannecker C, Jeschke U, Schmoeckel E, Mayr D, Heidegger HH, Vattai A, Burgmann M, Czogalla B, Mahner S, Fuerst S. Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients. Diagnostics (Basel). 2021 Mar 10;11(3):491. doi: 10.3390/diagnostics11030491. PMID: 33802010; PMCID: PMC8001561.
* Han N, Heublein S, Jeschke U, Kuhn C, Hester A, Czogalla B, Mahner S, Rottmann M, Mayr D, Schmoeckel E, Trillsch F. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro. Cells. 2021 Mar 11;10(3):619. doi: 10.3390/cells10030619. PMID: 33799631; PMCID: PMC8001910.
* Fraungruber P, Kaltofen T, Heublein S, Kuhn C, Mayr D, Burges A, Mahner S, Rathert P, Jeschke U, Trillsch F. G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients. Front Endocrinol (Lausanne). 2021 Feb 19;12:564002. doi: 10.3389/fendo.2021.564002. PMID: 33679613; PMCID: PMC7933595.
* Wang Q, Vattai A, Vilsmaier T, Kaltofen T, Steger A, Mayr D, Mahner S, Jeschke U, Hildegard Heidegger H. Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients. Int J Mol Sci. 2021 Feb 28;22(5):2442. doi: 10.3390/ijms22052442. PMID: 33671013; PMCID: PMC7957482.
* Trebo A, Ditsch N, Degenhardt T, Kuhn C, Rahmeh M, Schmoeckel E, Mayr D, Czogalla B, Kolben T, Meister S, Mahner S, Jeschke U, Hester A. First Evidence for a Role of Siglec-8 in Breast Cancer. Int J Mol Sci. 2021 Feb 18;22(4):2000. doi: 10.3390/ijms22042000. PMID: 33670444; PMCID: PMC7922794.
* Meister S, Hahn L, Beyer S, Kuhn C, Jegen M, von Schönfeldt V, Corradini S, Schulz C, Kolben TM, Hester A, Appelt T, Mahner S, Jeschke U, Kolben T. Epigenetic modification via H3K4me3 and H3K9ac in human placenta is reduced in preeclampsia. J Reprod Immunol. 2021 Jun;145:103287. doi: 10.1016/j.jri.2021.103287. Epub 2021 Feb 17. PMID: 33662848.
* Löb S, Amann N, Kuhn C, Schmoeckel E, Wöckel A, Zati Zehni A, Kaltofen T, Keckstein S, Mumm JN, Meister S, Kolben T, Mahner S, Jeschke U, Vilsmaier T. Interleukin-1 beta is significantly upregulated in the decidua of spontaneous and recurrent miscarriage placentas. J Reprod Immunol. 2021 Apr;144:103283. doi: 10.1016/j.jri.2021.103283. Epub 2021 Jan 30. PMID: 33545613.
* Zehni AZ, Batz F, Vattai A, Kaltofen T, Schrader S, Jacob SN, Mumm JN, Heidegger HH, Ditsch N, Mahner S, Jeschke U, Vilsmaier T. The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer. Int J Mol Sci. 2021 Jan 19;22(2):957. doi: 10.3390/ijms22020957. PMID: 33478016; PMCID: PMC7835829.
* Peng L, Yang H, Ye Y, Ma Z, Kuhn C, Rahmeh M, Mahner S, Makrigiannakis A, Jeschke U, von Schönfeldt V. Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Trophoblast Functions. Int J Mol Sci. 2021 Jan 4;22(1):433. doi: 10.3390/ijms22010433. PMID: 33406768; PMCID: PMC7795665.
* Löb S, Vattai A, Kuhn C, Schmoeckel E, Mahner S, Wöckel A, Kolben T, Keil C, Jeschke U, Vilsmaier T. Pregnancy Zone Protein (PZP) is significantly upregulated in the decidua of recurrent and spontaneous miscarriage and negatively correlated to Glycodelin A (GdA). J Reprod Immunol. 2021 Feb;143:103267. doi: 10.1016/j.jri.2020.103267. Epub 2020 Dec 24. PMID: 33388716.
* Czogalla B, Partenheimer A, Badmann S, Schmoeckel E, Mayr D, Kolben T, Beyer S, Hester A, Burges A, Mahner S, Jeschke U, Trillsch F. Nuclear Enolase-1/ MBP-1 expression and its association with the Wnt signaling in epithelial ovarian cancer. Transl Oncol. 2021 Jan;14(1):100910. doi: 10.1016/j.tranon.2020.100910. Epub 2020 Oct 14. PMID: 33069100; PMCID: PMC7569221.
* Vilsmaier T, Heidegger HH, Schröder L, Trapp E, Zehni AZ, Rack B, Janni W, Mahner S, Weissenbacher T, Jeschke U, Mumm JN; SUCCESS Study Group. Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status. Arch Gynecol Obstet. 2021 Jan;303(1):217-230. doi: 10.1007/s00404-020-05793-y. Epub 2020 Sep 14. PMID: 32929618; PMCID: PMC7854415.
* Binder J, Palmrich P, Kalafat E, Pateisky P, Öztürk E, Mittelberger J, Khalil A. Prognostic Value of Angiogenic Markers in Pregnant Women With Chronic Hypertension. J Am Heart Assoc. 2021 Sep 7;10(17):e020631. doi: 10.1161/JAHA.120.020631. Epub 2021 Aug 28. PMID: 34459247; PMCID: PMC8649241.
* Friedrich M, Kühn T, Janni W, Müller V, Banys-Paluchowski M, Kolberg-Liedtke C, Jackisch C, Krug D, Albert US, Bauerfeind I, Blohmer J, Budach W, Dall P, Fallenberg EM, Fasching PA, Fehm T, Gerber B, Gluz O, Hanf V, Harbeck N, Heil J, Huober J, Kreipe HH, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, Möbus V, Mundhenke C, Nitz U, Park-Simon TW, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Untch M, Witzel I, Wöckel A, Thill M, Ditsch N. Correction: AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update. Geburtshilfe Frauenheilkd. 2021 Oct 22;81(10):e31. doi: 10.1055/a-1674-1114. Erratum for: Geburtshilfe Frauenheilkd. 2021 Oct;81(10):1112-1120. PMID: 34720743; PMCID: PMC8548988.
* Friedrich M, Kühn T, Janni W, Müller V, Banys-Pachulowski M, Kolberg-Liedtke C, Jackisch C, Krug D, Albert US, Bauerfeind I, Blohmer J, Budach W, Dall P, Fallenberg EM, Fasching PA, Fehm T, Gerber B, Gluz O, Hanf V, Harbeck N, Heil J, Huober J, Kreipe HH, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, Möbus V, Mundhenke C, Nitz U, Park-Simon TW, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Untch M, Witzel I, Wöckel A, Thill M, Ditsch N. AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update. Geburtshilfe Frauenheilkd. 2021 Oct;81(10):1112-1120. doi: 10.1055/a-1499-8431. Epub 2021 Oct 6. Erratum in: Geburtshilfe Frauenheilkd. 2021 Oct 22;81(10):e31. PMID: 34629490; PMCID: PMC8494519.
* Rippinger N, Fischer C, Sinn HP, Dikow N, Sutter C, Rhiem K, Grill S, Cremer FW, Nguyen HP, Ditsch N, Kast K, Hettmer S, Kratz CP, Schott S. Breast cancer characteristics and surgery among women with Li-Fraumeni syndrome in Germany-A retrospective cohort study. Cancer Med. 2021 Nov;10(21):7747-7758. doi: 10.1002/cam4.4300. Epub 2021 Sep 26. PMID: 34569185; PMCID: PMC8559485.
* Thill M, Friedrich M, Kolberg-Liedtke C, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, Budach W, Dall P, Fallenberg EM, Fasching PA, Fehm T, Gerber B, Gluz O, Harbeck N, Heil J, Huober J, Jackisch C, Kreipe HH, Krug D, Kühn T, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, Mundhenke C, Nitz U, Park-Simon TW, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Untch M, Witzel I, Wöckel A, Müller V, Janni W, Ditsch N. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021. Breast Care (Basel). 2021 Jun;16(3):228-235. doi: 10.1159/000516420. Epub 2021 May 27. PMID: 34248463; PMCID: PMC8248779.
* Ditsch N, Kolberg-Liedtke C, Friedrich M, Jackisch C, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, Budach W, Dall P, Fallenberg EM, Fasching PA, Fehm T, Gerber B, Gluz O, Harbeck N, Heil J, Huober J, Kreipe HH, Krug D, Kühn T, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, Mundhenke C, Nitz U, Park-Simon TW, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Untch M, Witzel I, Wöckel A, Müller V, Janni W, Thill M. AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021. Breast Care (Basel). 2021 Jun;16(3):214-227. doi: 10.1159/000516419. Epub 2021 Jun 1. PMID: 34248462; PMCID: PMC8248778.
* Ditsch N, Stickeler E, Behrens A, Belleville E, Fasching PA, Fehm TN, Hartkopf AD, Jackisch C, Janni W, Kolberg-Liedtke C, Kolberg HC, Lüftner D, Lux MP, Müller V, Schneeweiss A, Schütz F, Schulmeyer CE, Tesch H, Thomssen C, Uleer C, Untch M, Welslau M, Wöckel A, Wurmthaler LA, Würstlein R, Thill M, Aktas B. Update Breast Cancer 2021 Part 2 - Advanced Stages, Long-Term Consequences and Biomarkers. Geburtshilfe Frauenheilkd. 2021 May;81(5):539-548. doi: 10.1055/a-1464-1221. Epub 2021 May 3. PMID: 34035548; PMCID: PMC8137275.
* Stickeler E, Aktas B, Behrens A, Belleville E, Ditsch N, Fasching PA, Fehm TN, Hartkopf AD, Jackisch C, Janni W, Kolberg-Liedtke C, Kolberg HC, Lüftner D, Lux MP, Müller V, Schneeweiss A, Schütz F, Schulmeyer CE, Tesch H, Thomssen C, Uleer C, Untch M, Welslau M, Wöckel A, Wurmthaler LA, Würstlein R, Thill M. Update Breast Cancer 2021 Part 1 - Prevention and Early Stages. Geburtshilfe Frauenheilkd. 2021 May;81(5):526-538. doi: 10.1055/a-1464-0953. Epub 2021 May 3. PMID: 34035547; PMCID: PMC8137274.
* Gasparri ML, Kuehn T, Ruscito I, Zuber V, Di Micco R, Galiano I, Navarro Quinones SC, Santurro L, Di Vittorio F, Meani F, Bassi V, Ditsch N, Mueller MD, Bellati F, Caserta D, Papadia A, Gentilini OD. Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials. Cancers (Basel). 2021 Apr 24;13(9):2056. doi: 10.3390/cancers13092056. PMID: 33923153; PMCID: PMC8123055.
* Lux MP, Schneeweiss A, Hartkopf AD, Müller V, Janni W, Belleville E, Stickeler E, Thill M, Fasching PA, Kolberg HC, Untch M, Harbeck N, Wöckel A, Thomssen C, Schulmeyer CE, Welslau M, Overkamp F, Schütz F, Lüftner D, Ditsch N. Update Breast Cancer 2020 Part 5 - Moving Therapies From Advanced to Early Breast Cancer Patients. Geburtshilfe Frauenheilkd. 2021 Apr;81(4):469-480. doi: 10.1055/a-1397-7170. Epub 2021 Apr 14. PMID: 33867564; PMCID: PMC8046519.
* Grill S, Ramser J, Hellebrand H, Pfarr N, Boxberg M, Brambs C, Ditsch N, Meindl A, Groß E, Meitinger T, Kiechle M, Quante AS. TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge. Arch Gynecol Obstet. 2021 Jun;303(6):1557-1567. doi: 10.1007/s00404-020-05883-x. Epub 2020 Nov 27. PMID: 33245408; PMCID: PMC8087555.
* Schaal NK, Hagenbeck C, Helbig M, Wulff V, Märthesheimer S, Fehm T, Hepp P. The influence of being pregnant during the COVID-19 pandemic on birth expectations and antenatal bonding. J Reprod Infant Psychol. 2021 Aug 18:1-11. doi: 10.1080/02646838.2021.1962825. Epub ahead of print. PMID: 34407711.
* Wulff V, Hepp P, Wolf OT, Fehm T, Schaal NK. The influence of maternal singing on well-being, postpartum depression and bonding - a randomised, controlled trial. BMC Pregnancy Childbirth. 2021 Jul 12;21(1):501. doi: 10.1186/s12884-021-03933-z. PMID: 34247578; PMCID: PMC8273948.
* Schaal NK, Brückner J, Wolf OT, Ruckhäberle E, Fehm T, Hepp P. The effects of a music intervention during port catheter placement on anxiety and stress. Sci Rep. 2021 Mar 11;11(1):5807. doi: 10.1038/s41598-021-85139-z. PMID: 33707520; PMCID: PMC7970967.
* Hepp P, Fleisch M, Hasselbach K, Fehm T, Schaal NK. Use of music during vaginal birth and caesarean section: an interprofessional survey. Arch Gynecol Obstet. 2021 Aug;304(2):355-363. doi: 10.1007/s00404-020-05958-9. Epub 2021 Jan 24. PMID: 33486579; PMCID: PMC8277630.
* Wulff V, Hepp P, Wolf OT, Balan P, Hagenbeck C, Fehm T, Schaal NK. The effects of a music and singing intervention during pregnancy on maternal well-being and mother-infant bonding: a randomised, controlled study. Arch Gynecol Obstet. 2021 Jan;303(1):69-83. doi: 10.1007/s00404-020-05727-8. Epub 2020 Aug 10. PMID: 32776296; PMCID: PMC7854426.
* AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020. Ditsch N, Untch M, Kolberg-Liedtke C, Jackisch C, Krug D, Friedrich M, Janni W, Müller V, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, Budach W, Dall P, Diel I, Fallenberg EM, Fasching PA, Fehm T, Gerber B, Gluz O, Hanf V, Harbeck N, Heil J, Huober J, Kreipe HH, Kühn T, Kümmel S, Loibl S, Lüftner D, Lux M, Maass N, Moebus V, Mundhenke C, Park-Simon TW, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Witzel I, Wöckel A, Thill M. Breast Care (Basel). 2020 Jun;15(3):294-309. doi: 10.1159/000508736. Epub 2020 Jun 10.PMID: 32774225 Review.
* TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge. Grill S, Ramser J, Hellebrand H, Pfarr N, Boxberg M, Brambs C, Ditsch N, Meindl A, Groß E, Meitinger T, Kiechle M, Quante AS. Arch Gynecol Obstet. 2020 Nov 27. doi: 10.1007/s00404-020-05883-x. Online ahead of print.PMID: 33245408
* Breast and axillary surgery in malignant breast disease: a review focused on literature of 2018 and 2019. Ditsch N, Rubio IT, Gasparri ML, de Boniface J, Kuehn T. Curr Opin Obstet Gynecol. 2020 Feb;32(1):91-99. doi: 10.1097/GCO.0000000000000593.PMID: 31833973
* Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: A multicenter feasibility and acceptance survey. Rippinger N, Fischer C, Haun MW, Rhiem K, Grill S, Kiechle M, Cremer FW, Kast K, Nguyen HP, Ditsch N, Kratz CP, Vogel J, Speiser D, Hettmer S, Glimm H, Fröhling S, Jäger D, Seitz S, Hahne A, Maatouk I, Sutter C, Schmutzler RK, Dikow N, Schott S. Cancer. 2020 Sep 1;126(17):4032-4041. doi: 10.1002/cncr.33004. Epub 2020 Jun 18.PMID: 32557628
* Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03. Heil J, Pfob A, Sinn HP, Rauch G, Bach P, Thomas B, Schaefgen B, Kuemmel S, Reimer T, Hahn M, Thill M, Blohmer JU, Hackmann J, Malter W, Bekes I, Friedrichs K, Wojcinski S, Joos S, Paepke S, Ditsch N, Rody A, Große R, van Mackelenbergh M, Reinisch M, Karsten M, Golatta M; RESPONDER Investigators. Ann Surg. 2020 Jul 9. doi: 10.1097/SLA.0000000000004246. Online ahead of print.PMID: 32657944
* Impact of Granulocyte Colony-Stimulating Factor (G-CSF) and Epoetin (EPO) on Hematologic Toxicities and Quality of Life in Patients During Adjuvant Chemotherapy in Early Breast Cancer: Results From the Multi-Center Randomized ADEBAR Trial. Bekes I, Eichler M, Singer S, Friedl TWP, Harbeck N, Rack B, Forstbauer H, Dannecker C, Huober J, Kiechle M, Lato K, Janni W, Fink V. Clin Breast Cancer. 2020 Dec;20(6):439-447. doi: 10.1016/j.clbc.2020.03.008. Epub 2020 Apr 6.PMID: 32800493
* Rationale and description of a lifestyle intervention programme to achieve moderate weight loss in women with non-metastatic breast cancer: the lifestyle intervention part of the SUCCESS C Study. Hauner D, Rack B, Friedl T, Hepp P, Janni W, Hauner H.BMJ Nutr Prev Health. 2020 Sep 21;3(2):213-219. doi: 10.1136/bmjnph-2020-000119. eCollection 2020 Dec.PMID: 33521531
* PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva. Czogalla B, Pham D, Trillsch F, Rottmann M, Gallwas J, Burges A, Mahner S, Kirchner T, Jeschke U, Mayr D, Schmoeckel E. J Cancer Res Clin Oncol. 2020 Mar;146(3):569-577. doi: 10.1007/s00432-020-03126-9. Epub 2020 Feb 5. PMID: 32025868 Free PMC article.
* [Corrigendum] Effects of green tea, matcha tea and their components epigallocatechin gallate and quercetin on MCF-7 and MDA-MB-231 breast carcinoma cells. Schröder L, Marahrens P, Koch JG, Heidegger H, Vilsmaier T, Phan-Brehm T, Hofmann S, Mahner S, Jeschke U, Richter DU. Oncol Rep. 2020 Feb;43(2):747. doi: 10.3892/or.2019.7430. Epub 2019 Dec 13. PMID: 31894277
* Oropharyngeal HPV Detection Techniques in HPV-associated Head and Neck Cancer Patients. Eggersmann TK, Baumeister P, Kumbrink J, Mayr D, Schmoeckel E, Thaler CJ, Dannecker C, Jeschke U, Nagler T, Mahner S, Sharaf K, Gallwas JKS. Anticancer Res. 2020 Apr;40(4):2117-2123. doi: 10.21873/anticanres.14170. PMID: 32234904
* The Distinct Roles of Transcriptional Factor KLF11 in Normal Cell Growth Regulation and Cancer as a Mediator of TGF-β Signaling Pathway. Lin L, Mahner S, Jeschke U, Hester A.
Int J Mol Sci. 2020 Apr 22;21(8):2928. doi: 10.3390/ijms21082928. PMID: 32331236
* COX-2-PGE2-EPs in gynecological cancers. Ye Y, Wang X, Jeschke U, von Schönfeldt V. Arch Gynecol Obstet. 2020 Jun;301(6):1365-1375. doi: 10.1007/s00404-020-05559-6. Epub 2020 May 3. PMID: 32363546
* Expression of H3K4me3 and H3K9ac in breast cancer. Berger L, Kolben T, Meister S, Kolben TM, Schmoeckel E, Mayr D, Mahner S, Jeschke U, Ditsch N, Beyer S. J Cancer Res Clin Oncol. 2020 Aug;146(8):2017-2027. doi: 10.1007/s00432-020-03265-z. Epub 2020 May 28. PMID: 32468423
* The role of EP-2 receptor expression in cervical intraepithelial neoplasia. Schmoeckel E, Fraungruber P, Kuhn C, Jeschke U, Mahner S, Kolben TM, Kolben T, Vilsmaier T, Hester A, Heidegger HH. Histochem Cell Biol. 2020 Dec;154(6):655-662. doi: 10.1007/s00418-020-01909-2. Epub 2020 Aug 26. PMID: 32851536
* Cytoplasmic VDR expression as an independent risk factor for ovarian cancer. Czogalla B, Deuster E, Liao Y, Mayr D, Schmoeckel E, Sattler C, Kolben T, Hester A, Fürst S, Burges A, Mahner S, Jeschke U, Trillsch F. Histochem Cell Biol. 2020 Oct;154(4):421-429. doi: 10.1007/s00418-020-01894-6. Epub 2020 Jun 22. PMID: 32572587
* Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer. Beyer S, Chen F, Meister S, Czogalla B, Kolben TM, Hester A, Burges A, Trillsch F, Schmöckel E, Mayr D, Mayerhofer A, Mahner S, Jeschke U, Kolben T. Histochem Cell Biol. 2020 Aug;154(2):189-195. doi: 10.1007/s00418-020-01873-x. Epub 2020 May 9. PMID: 32388637
* Lysine-specific histone demethylase 1A (LSD1) in cervical cancer. Beilner D, Kuhn C, Kost BP, Jückstock J, Mayr D, Schmoeckel E, Dannecker C, Mahner S, Jeschke U, Heidegger HH. J Cancer Res Clin Oncol. 2020 Nov;146(11):2843-2850. doi: 10.1007/s00432-020-03338-z. Epub 2020 Jul 28. PMID: 32725356
* MSX1-A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas. Eppich S, Kuhn C, Schmoeckel E, Mayr D, Mahner S, Jeschke U, Gallwas J, Heidegger HH. Int J Mol Sci. 2020 Jun 25;21(12):4529. doi: 10.3390/ijms21124529. PMID: 32630554
* LDOC1 as Negative Prognostic Marker for Vulvar Cancer Patients. Wanka G, Schmoeckel E, Mayr D, Fuerst S, Kuhn C, Mahner S, Knabl J, Karsten MM, Dannecker C, Heidegger HH, Vattai A, Jeschke U, Jueckstock J. Int J Mol Sci. 2020 Dec 5;21(23):9287. doi: 10.3390/ijms21239287. PMID: 33291445
* The prostaglandin receptor EP2 determines prognosis in EP3-negative and galectin-3-high cervical cancer cases. Dietlmeier S, Ye Y, Kuhn C, Vattai A, Vilsmaier T, Schröder L, Kost BP, Gallwas J, Jeschke U, Mahner S, Heidegger HH. Sci Rep. 2020 Jan 24;10(1):1154. doi: 10.1038/s41598-020-58095-3. PMID: 31980713
* Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients. Ditsch N, Heublein S, Jeschke U, Sattler C, Kuhn C, Hester A, Czogalla B, Trillsch F, Mahner S, Engel J, Mayr D, Schmoeckel E. J Cancer Res Clin Oncol. 2020 Aug;146(8):1923-1932. doi: 10.1007/s00432-020-03241-7. Epub 2020 Jun 12. PMID: 32533406
* Evaluation of the anti-Thomsen-Friedenreich antibodies Nemod-TF1 and Nemod-TF2 as prognostic markers in breast cancer. Heublein S, Egger M, Zhu J, Berger L, Mayr D, Schindlbeck C, Kuhn C, Hofmann SS, Schuetz F, Jeschke U, Ditsch N. Breast Cancer Res Treat. 2020 Feb;179(3):643-652. doi: 10.1007/s10549-019-05503-6. Epub 2019 Dec 11. PMID: 31828591
* Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer. Kaltofen T, Preinfalk V, Schwertler S, Fraungruber P, Heidegger H, Vilsmaier T, Vattai A, Czogalla B, Mayr D, Mahner S, Jeschke U, Trillsch F. J Cancer Res Clin Oncol. 2020 Oct;146(10):2559-2574. doi: 10.1007/s00432-020-03317-4. Epub 2020 Jul 17. PMID: 32681294
* β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation. Czogalla B, Partenheimer A, Jeschke U, von Schönfeldt V, Mayr D, Mahner S, Burges A, Simoni M, Melli B, Benevelli R, Bertini S, Casarini L, Trillsch F. Front Endocrinol (Lausanne). 2020 Sep 18;11:554733. doi: 10.3389/fendo.2020.554733. eCollection 2020. PMID: 33042017
* H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology. Han N, Jeschke U, Kuhn C, Hester A, Czogalla B, Mahner S, Rottmann M, Mayr D, Schmoeckel E, Trillsch F. Int J Mol Sci. 2020 Mar 20;21(6):2151. doi: 10.3390/ijms21062151. PMID: 32245092
* Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers. Shao W, Kuhn C, Mayr D, Ditsch N, Kailuwait M, Wolf V, Harbeck N, Mahner S, Jeschke U, Cavaillès V, Sixou S.
J Transl Med. 2020 Feb 21;18(1):94. doi: 10.1186/s12967-020-02271-6. PMID: 32085795
* M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis. Badmann S, Heublein S, Mayr D, Reischer A, Liao Y, Kolben T, Beyer S, Hester A, Zeder-Goess C, Burges A, Mahner S, Jeschke U, Trillsch F, Czogalla B. Cells. 2020 May 15;9(5):1224. doi: 10.3390/cells9051224. PMID: 32429133
* Regulation of LCoR and RIP140 expression in cervical intraepithelial neoplasia and correlation with CIN progression and dedifferentiation. Vogelsang TLR, Schmoeckel E, Kuhn C, Blankenstein T, Temelkov M, Heidegger H, Kolben TM, Kolben T, Mahner S, Mayr D, Jeschke U, Vattai A. J Cancer Res Clin Oncol. 2020 Jul;146(7):1847-1855. doi: 10.1007/s00432-020-03178-x. Epub 2020 Mar 10. PMID: 32157438
* Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness. Patel VL, Busch EL, Friebel TM, Cronin A, Leslie G, McGuffog L, Adlard J, Agata S, Agnarsson BA, Ahmed M, Aittomäki K, Alducci E, Andrulis IL, Arason A, Arnold N, Artioli G, Arver B, Auber B, Azzollini J, Balmaña J, Barkardottir RB, Barnes DR, Barroso A, Barrowdale D, Belotti M, Benitez J, Bertelsen B, Blok MJ, Bodrogi I, Bonadona V, Bonanni B, Bondavalli D, Boonen SE, Borde J, Borg A, Bradbury AR, Brady A, Brewer C, Brunet J, Buecher B, Buys SS, Cabezas-Camarero S, Caldés T, Caliebe A, Caligo MA, Calvello M, Campbell IG, Carnevali I, Carrasco E, Chan TL, Chu ATW, Chung WK, Claes KBM, Collaborators GS, Collaborators E, Cook J, Cortesi L, Couch FJ, Daly MB, Damante G, Darder E, Davidson R, de la Hoya M, Puppa LD, Dennis J, Díez O, Ding YC, Ditsch N, Domchek SM, Donaldson A, Dworniczak B, Easton DF, Eccles DM, Eeles RA, Ehrencrona H, Ejlertsen B, Engel C, Evans DG, Faivre L, Faust U, Feliubadaló L, Foretova L, Fostira F, Fountzilas G, Frost D, García-Barberán V, Garre P, Gauthier-Villars M, Géczi L, Gehrig A, Gerdes AM, Gesta P, Giannini G, Glendon G, Godwin AK, Goldgar DE, Greene MH, Gutierrez-Barrera AM, Hahnen E, Hamann U, Hauke J, Herold N, Hogervorst FBL, Honisch E, Hopper JL, Hulick PJ, Investigators K, Investigators H, Izatt L, Jager A, James P, Janavicius R, Jensen UB, Jensen TD, Johannsson OT, John EM, Joseph V, Kang E, Kast K, Kiiski JI, Kim SW, Kim Z, Ko KP, Konstantopoulou I, Kramer G, Krogh L, Kruse TA, Kwong A, Larsen M, Lasset C, Lautrup C, Lazaro C, Lee J, Lee JW, Lee MH, Lemke J, Lesueur F, Liljegren A, Lindblom A, Llovet P, Lopez-Fernández A, Lopez-Perolio I, Lorca V, Loud JT, Ma ESK, Mai PL, Manoukian S, Mari V, Martin L, Matricardi L, Mebirouk N, Medici V, Meijers-Heijboer HEJ, Meindl A, Mensenkamp AR, Miller C, Gomes DM, Montagna M, Mooij TM, Moserle L, Mouret-Fourme E, Mulligan AM, Nathanson KL, Navratilova M, Nevanlinna H, Niederacher D, Nielsen FCC, Nikitina-Zake L, Offit K, Olah E, Olopade OI, Ong KR, Osorio A, Ott CE, Palli D, Park SK, Parsons MT, Pedersen IS, Peissel B, Peixoto A, Pérez-Segura P, Peterlongo P, Petersen AH, Porteous ME, Pujana MA, Radice P, Ramser J, Rantala J, Rashid MU, Rhiem K, Rizzolo P, Robson ME, Rookus MA, Rossing CM, Ruddy KJ, Santos C, Saule C, Scarpitta R, Schmutzler RK, Schuster H, Senter L, Seynaeve CM, Shah PD, Sharma P, Shin VY, Silvestri V, Simard J, Singer CF, Skytte AB, Snape K, Solano AR, Soucy P, Southey MC, Spurdle AB, Steele L, Steinemann D, Stoppa-Lyonnet D, Stradella A, Sunde L, Sutter C, Tan YY, Teixeira MR, Teo SH, Thomassen M, Tibiletti MG, Tischkowitz M, Tognazzo S, Toland AE, Tommasi S, Torres D, Toss A, Trainer AH, Tung N, van Asperen CJ, van der Baan FH, van der Kolk LE, van der Luijt RB, van Hest LP, Varesco L, Varon-Mateeva R, Viel A, Vierstraete J, Villa R, von Wachenfeldt A, Wagner P, Wang-Gohrke S, Wappenschmidt B, Weitzel JN, Wieme G, Yadav S, Yannoukakos D, Yoon SY, Zanzottera C, Zorn KK, D'Amico AV, Freedman ML, Pomerantz MM, Chenevix-Trench G, Antoniou AC, Neuhausen SL, Ottini L, Nielsen HR, Rebbeck TR.
Cancer Res. 2020 Feb 1;80(3):624-638. doi: 10.1158/0008-5472.CAN-19-1840. Epub 2019 Nov 13.PMID: 31723001
* A randomized trial comparing limited-excision conisation to Large Loop Excision of the Transformation Zone (LLETZ) in cervical dysplasia patients. Kolben TM, Etzel LT, Bergauer F, Hagemann I, Hillemanns P, Repper M, Kaufmann AM, Sotlar K, Kolben T, Helms HJ, Gallwas J, Mahner S, Dannecker C. J Gynecol Oncol. 2019 May;30(3):e42. doi: 10.3802/jgo.2019.30.e42.PMID: 30887760. Clinical Trial.
* Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia. Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M.Geburtshilfe Frauenheilkd. 2019 Feb;79(2):148-159. doi: 10.1055/a-0818-5440. Epub 2019 Feb 18.PMID: 30792545
* Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018). Schnürch HG, Ackermann S, Alt-Radtke CD, Angleitner L, Barinoff J, Beckmann MW, Böing C, Dannecker C, Fehm T, Gaase R, Gass P, Gebhardt M, Gieseking F, Günthert A, Hack CC, Hantschmann P, Horn LC, Koch MC, Letsch A, Mallmann P, Mangold B, Marnitz S, Mehlhorn G, Paradies K, Reinhardt MJ, Tholen R, Torsten U, Weikel W, Wölber L, Hampl M.Geburtshilfe Frauenheilkd. 2019 Oct;79(10):1060-1078. doi: 10.1055/a-0919-4959. Epub 2019 Jul 16.PMID: 31680701
* Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up. Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M.Geburtshilfe Frauenheilkd. 2019 Feb;79(2):160-176. doi: 10.1055/a-0828-7722. Epub 2019 Feb 18.PMID: 30792546
* [Breast cancer - a modern approach in oncoplastic surgery]. Hagemann F, Geiger P, Luczak C, Perabò M, Degenhardt T, Schenck T, Mahner S, Harbeck N, Ditsch N. MMW Fortschr Med. 2019 Aug;161(14):47-50. doi: 10.1007/s15006-019-0784-1.PMID: 31414430 Review. German.
* AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019. Ditsch N, Untch M, Thill M, Müller V, Janni W, Albert US, Bauerfeind I, Blohmer J, Budach W, Dall P, Diel I, Fasching PA, Fehm T, Friedrich M, Gerber B, Hanf V, Harbeck N, Huober J, Jackisch C, Kolberg-Liedtke C, Kreipe HH, Krug D, Kühn T, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, Möbus V, Müller-Schimpfle M, Mundhenke C, Nitz U, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Wenz F, Witzel I, Wöckel A.Breast Care (Basel). 2019 Aug;14(4):224-245. doi: 10.1159/000501000. Epub 2019 Aug 6.PMID: 31558897
* The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status. Jeschke U, Zhang X, Kuhn C, Jalaguier S, Colinge J, Pfender K, Mayr D, Ditsch N, Harbeck N, Mahner S, Sixou S, Cavaillès V.Int J Mol Sci. 2019 Feb 26;20(5):1016. doi: 10.3390/ijms20051016.PMID: 30813617
* Effects of green tea, matcha tea and their components epigallocatechin gallate and quercetin on MCF-7 and MDA-MB-231 breast carcinoma cells. Schröder L, Marahrens P, Koch JG, Heidegger H, Vilsmeier T, Phan-Brehm T, Hofmann S, Mahner S, Jeschke U, Richter DU. Oncol Rep. 2019 Jan;41(1):387-396. doi: 10.3892/or.2018.6789. Epub 2018 Oct 12. PMID: 30320348
* Breast cancer, placenta and pregnancy. Froehlich K, Schmidt A, Heger JI, Al-Kawlani B, Aberl CA, Jeschke U, Loibl S, Markert UR. Eur J Cancer. 2019 Jul;115:68-78. doi: 10.1016/j.ejca.2019.03.021. Epub 2019 May 20. PMID: 31121525 Review.
* The Formation and Therapeutic Update of Tumor-Associated Macrophages in Cervical Cancer. Wang Q, Steger A, Mahner S, Jeschke U, Heidegger H. Int J Mol Sci. 2019 Jul 5;20(13):3310. doi: 10.3390/ijms20133310. PMID: 31284453
* Extracapsular Lymph Node Involvement in Ovarian Carcinoma. Heublein S, Schulz H, Marmé F, Angele M, Czogalla B, Burges A, Mahner S, Mayr D, Jeschke U, Schmoeckel E. Cancers (Basel). 2019 Jul 1;11(7):924. doi: 10.3390/cancers11070924. PMID: 31266250
* Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification. Parsons MT, Tudini E, Li H, Hahnen E, Wappenschmidt B, Feliubadaló L, Aalfs CM, Agata S, Aittomäki K, Alducci E, Alonso-Cerezo MC, Arnold N, Auber B, Austin R, Azzollini J, Balmaña J, Barbieri E, Bartram CR, Blanco A, Blümcke B, Bonache S, Bonanni B, Borg Å, Bortesi B, Brunet J, Bruzzone C, Bucksch K, Cagnoli G, Caldés T, Caliebe A, Caligo MA, Calvello M, Capone GL, Caputo SM, Carnevali I, Carrasco E, Caux-Moncoutier V, Cavalli P, Cini G, Clarke EM, Concolino P, Cops EJ, Cortesi L, Couch FJ, Darder E, de la Hoya M, Dean M, Debatin I, Del Valle J, Delnatte C, Derive N, Diez O, Ditsch N, Domchek SM, Dutrannoy V, Eccles DM, Ehrencrona H, Enders U, Evans DG, Farra C, Faust U, Felbor U, Feroce I, Fine M, Foulkes WD, Galvao HCR, Gambino G, Gehrig A, Gensini F, Gerdes AM, Germani A, Giesecke J, Gismondi V, Gómez C, Gómez Garcia EB, González S, Grau E, Grill S, Gross E, Guerrieri-Gonzaga A, Guillaud-Bataille M, Gutiérrez-Enríquez S, Haaf T, Hackmann K, Hansen TVO, Harris M, Hauke J, Heinrich T, Hellebrand H, Herold KN, Honisch E, Horvath J, Houdayer C, Hübbel V, Iglesias S, Izquierdo A, James PA, Janssen LAM, Jeschke U, Kaulfuß S, Keupp K, Kiechle M, Kölbl A, Krieger S, Kruse TA, Kvist A, Lalloo F, Larsen M, Lattimore VL, Lautrup C, Ledig S, Leinert E, Lewis AL, Lim J, Loeffler M, López-Fernández A, Lucci-Cordisco E, Maass N, Manoukian S, Marabelli M, Matricardi L, Meindl A, Michelli RD, Moghadasi S, Moles-Fernández A, Montagna M, Montalban G, Monteiro AN, Montes E, Mori L, Moserle L, Müller CR, Mundhenke C, Naldi N, Nathanson KL, Navarro M, Nevanlinna H, Nichols CB, Niederacher D, Nielsen HR, Ong KR, Pachter N, Palmero EI, Papi L, Pedersen IS, Peissel B, Perez-Segura P, Pfeifer K, Pineda M, Pohl-Rescigno E, Poplawski NK, Porfirio B, Quante AS, Ramser J, Reis RM, Revillion F, Rhiem K, Riboli B, Ritter J, Rivera D, Rofes P, Rump A, Salinas M, Sánchez de Abajo AM, Schmidt G, Schoenwiese U, Seggewiß J, Solanes A, Steinemann D, Stiller M, Stoppa-Lyonnet D, Sullivan KJ, Susman R, Sutter C, Tavtigian SV, Teo SH, Teulé A, Thomassen M, Tibiletti MG, Tischkowitz M, Tognazzo S, Toland AE, Tornero E, Törngren T, Torres-Esquius S, Toss A, Trainer AH, Tucker KM, van Asperen CJ, van Mackelenbergh MT, Varesco L, Vargas-Parra G, Varon R, Vega A, Velasco Á, Vesper AS, Viel A, Vreeswijk MPG, Wagner SA, Waha A, Walker LC, Walters RJ, Wang-Gohrke S, Weber BHF, Weichert W, Wieland K, Wiesmüller L, Witzel I, Wöckel A, Woodward ER, Zachariae S, Zampiga V, Zeder-Göß C; KConFab Investigators, Lázaro C, De Nicolo A, Radice P, Engel C, Schmutzler RK, Goldgar DE, Spurdle AB. Hum Mutat. 2019 Sep;40(9):1557-1578. doi: 10.1002/humu.23818.
* EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer. Czogalla B, Kuhn C, Heublein S, Schmöckel E, Mayr D, Kolben T, Trillsch F, Burges A, Mahner S, Jeschke U, Hester A. J Cancer Res Clin Oncol. 2019 Oct;145(10):2519-2527. doi: 10.1007/s00432-019-03017-8. Epub 2019 Sep 4. PMID: 31485769
* Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer. Heublein S, Page S, Mayr D, Schmoeckel E, Trillsch F, Marmé F, Mahner S, Jeschke U, Vattai A. Int J Mol Sci. 2019 Jan 12;20(2):295. doi: 10.3390/ijms20020295. PMID: 30642093
* Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients. Deuster E, Mayr D, Hester A, Kolben T, Zeder-Göß C, Burges A, Mahner S, Jeschke U, Trillsch F, Czogalla B. Int J Mol Sci. 2019 Jun 12;20(12):2862. doi: 10.3390/ijms20122862. PMID: 31212758
* Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology. Czogalla B, Kahaly M, Mayr D, Schmoeckel E, Niesler B, Hester A, Zeder-Göß C, Kolben T, Burges A, Mahner S, Jeschke U, Trillsch F. Cancer Manag Res. 2019 Aug 14;11:7673-7684. doi: 10.2147/CMAR.S210004. eCollection 2019. PMID: 31616183
* Higher CCL22+ Cell Infiltration is Associated with Poor Prognosis in Cervical Cancer Patients. Wang Q, Schmoeckel E, Kost BP, Kuhn C, Vattai A, Vilsmaier T, Mahner S, Mayr D, Jeschke U, Heidegger HH. Cancers (Basel). 2019 Dec 12;11(12):2004. doi: 10.3390/cancers11122004. PMID: 31842422
* EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells. Hester A, Salzmann B, Rahmeh M, Kolben T, Czogalla B, Ditsch N, Mahner S, Jeschke U, Kolben TM. Onco Targets Ther. 2019 Jul 29;12:6053-6068. doi: 10.2147/OTT.S204919. eCollection 2019. PMID: 31534346
* The role of EP3-receptor expression in cervical dysplasia. Hester A, Ritzer M, Kuhn C, Schmoeckel E, Mayr D, Kolben T, Dannecker C, Mahner S, Jeschke U, Kolben TM. J Cancer Res Clin Oncol. 2019 Feb;145(2):313-319. doi: 10.1007/s00432-018-2785-3. Epub 2018 Nov 7. PMID: 30402741
* Glucocorticoid receptor in cervical cancer: an immunhistochemical analysis. Kost BP, Beyer S, Schröder L, Zhou J, Mayr D, Kuhn C, Schulze S, Hofmann S, Mahner S, Jeschke U, Heidegger H. Arch Gynecol Obstet. 2019 Jan;299(1):203-209. doi: 10.1007/s00404-018-4928-9. Epub 2018 Oct 10. PMID: 30306311
* Prognostic relevance of RIP140 and ERβ expression in unifocal versus multifocal breast cancers: a preliminary report. Müller K, Sixou S, Kuhn C, Jalaguier S, Mayr D, Ditsch N, Weissenbacher T, Harbeck N, Mahner S, Cavaillès V, Jeschke U. Int J Mol Sci. 2019 Jan 18;20(2):418. doi: 10.3390/ijms20020418. PMID: 30669416
* Glucocorticoid receptors α and β are modulated sex specifically in human placentas of intrauterine growth restriction (IUGR). Hutter S, Hepp P, Hofmann S, Kuhn C, Messner J, Andergassen U, Mayr D, Emilia Solano M, Obermeier V, Mahner S, Arck P, Jeschke U. Arch Gynecol Obstet. 2019 Aug;300(2):323-335. doi: 10.1007/s00404-019-05189-7. Epub 2019 May 14. PMID: 31089804
* The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status. Jeschke U, Zhang X, Kuhn C, Jalaguier S, Colinge J, Pfender K, Mayr D, Ditsch N, Harbeck N, Mahner S, Sixou S, Cavaillès V. Int J Mol Sci. 2019 Feb 26;20(5):1016. doi: 10.3390/ijms20051016.PMID: 30813617
* Lymph node dissection in endometrial cancer and clinical outcome: A population-based study in 5546 patients. Pölcher M, Rottmann M, Brugger S, Mahner S, Dannecker C, Kiechle M, Brambs C, Grab D, Anthuber C, von Koch F, Schnelzer A, Engel J.Gynecol Oncol. 2019 Jul;154(1):65-71. doi: 10.1016/j.ygyno.2019.04.002. Epub 2019 Apr 23.PMID: 31027900
* Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer. Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators. N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361.PMID: 31851799 Clinical Trial.
* [Breast cancer in young women]. Burgmann DM, Dobler F, Zeder-Göss C, Mahner S, Harbeck N, Würstlein R. MMW Fortschr Med. 2019 Aug;161(14):43-47. doi: 10.1007/s15006-019-0783-2.PMID: 31414431 Review.
* Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study. Hennigs A, Riedel F, Feißt M, Köpke M, Rezai M, Nitz U, Moderow M, Golatta M, Sohn C, Heil J. Ann Surg Oncol. 2019 Aug;26(8):2435-2443. doi: 10.1245/s10434-019-07388-7. Epub 2019 May 2.PMID: 31049766
* Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?Hennigs A, Köpke M, Feißt M, Riedel F, Rezai M, Nitz U, Moderow M, Golatta M, Sohn C, Schneeweiss A, Heil J. Breast Cancer Res Treat. 2019 Jan;173(2):429-438. doi: 10.1007/s10549-018-5009-2. Epub 2018 Oct 12.PMID: 30315437
* EndoPredict versus uPA/PAI-1 in breast cancer: Comparison of markers and association with clinicopathological parameters. Jakubowicz E, Martin B, Hoffmann R, Kröncke T, Jung T, Steierl R, Steinfeld D, Schenkirsch G, Kriegsmann J, Märkl B. Breast J. 2019 May;25(3):450-454. doi: 10.1111/tbj.13258. Epub 2019 Apr 18.PMID: 31001905
* Impact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancer. Märkl B, Kazik M, Harbeck N, Jakubowicz E, Hoffmann R, Jung T, Steinfeld D, Schenkirsch G, Schlimok G, Oruzio D.BMC Cancer. 2019 Jul 15;19(1):692. doi: 10.1186/s12885-019-5857-0.PMID: 31307406
* AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019. Thill M, Jackisch C, Janni W, Müller V, Albert US, Bauerfeind I, Blohmer J, Budach W, Dall P, Diel I, Fasching PA, Fehm T, Friedrich M, Gerber B, Hanf V, Harbeck N, Huober J, Kolberg-Liedtke C, Kreipe HH, Krug D, Kühn T, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, Möbus V, Müller-Schimpfle M, Mundhenke C, Nitz U, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Untch M, Wenz F, Witzel I, Wöckel A, Ditsch N. Breast Care (Basel). 2019 Aug;14(4):247-255. doi: 10.1159/000500999. Epub 2019 Jul 30.PMID: 31558898
* Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer. Ditsch N, Schmidt M. Geburtshilfe Frauenheilkd. 2019 Dec;79(12):1328-1335. doi: 10.1055/a-1037-5205. Epub 2019 Dec 11.PMID: 31875862
* The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. Figlioli G, Bogliolo M, Catucci I, Caleca L, Lasheras SV, Pujol R, Kiiski JI, Muranen TA, Barnes DR, Dennis J, Michailidou K, Bolla MK, Leslie G, Aalfs CM; ABCTB Investigators, Adank MA, Adlard J, Agata S, Cadoo K, Agnarsson BA, Ahearn T, Aittomäki K, Ambrosone CB, Andrews L, Anton-Culver H, Antonenkova NN, Arndt V, Arnold N, Aronson KJ, Arun BK, Asseryanis E, Auber B, Auvinen P, Azzollini J, Balmaña J, Barkardottir RB, Barrowdale D, Barwell J, Beane Freeman LE, Beauparlant CJ, Beckmann MW, Behrens S, Benitez J, Berger R, Bermisheva M, Blanco AM, Blomqvist C, Bogdanova NV, Bojesen A, Bojesen SE, Bonanni B, Borg A, Brady AF, Brauch H, Brenner H, Brüning T, Burwinkel B, Buys SS, Caldés T, Caliebe A, Caligo MA, Campa D, Campbell IG, Canzian F, Castelao JE, Chang-Claude J, Chanock SJ, Claes KBM, Clarke CL, Collavoli A, Conner TA, Cox DG, Cybulski C, Czene K, Daly MB, de la Hoya M, Devilee P, Diez O, Ding YC, Dite GS, Ditsch N, Domchek SM, Dorfling CM, Dos-Santos-Silva I, Durda K, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Ellberg C, Eriksson M, Evans DG, Fasching PA, Figueroa J, Flyger H, Foulkes WD, Friebel TM, Friedman E, Gabrielson M, Gaddam P, Gago-Dominguez M, Gao C, Gapstur SM, Garber J, García-Closas M, García-Sáenz JA, Gaudet MM, Gayther SA; GEMO Study Collaborators, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, Guénel P, Gutierrez-Barrera AM, Haeberle L, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hein A, Heyworth J, Hillemanns P, Hollestelle A, Hopper JL, Hosgood HD 3rd, Howell A, Hu C, Hulick PJ, Hunter DJ, Imyanitov EN; KConFab, Isaacs C, Jakimovska M, Jakubowska A, James P, Janavicius R, Janni W, John EM, Jones ME, Jung A, Kaaks R, Karlan BY, Khusnutdinova E, Kitahara CM, Konstantopoulou I, Koutros S, Kraft P, Lambrechts D, Lazaro C, Le Marchand L, Lester J, Lesueur F, Lilyquist J, Loud JT, Lu KH, Luben RN, Lubinski J, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martens JWM, Maurer T, Mavroudis D, Mebirouk N, Meindl A, Menon U, Miller A, Montagna M, Nathanson KL, Neuhausen SL, Newman WG, Nguyen-Dumont T, Nielsen FC, Nielsen S, Nikitina-Zake L, Offit K, Olah E, Olopade OI, Olshan AF, Olson JE, Olsson H, Osorio A, Ottini L, Peissel B, Peixoto A, Peto J, Plaseska-Karanfilska D, Pocza T, Presneau N, Pujana MA, Punie K, Rack B, Rantala J, Rashid MU, Rau-Murthy R, Rennert G, Lejbkowicz F, Rhenius V, Romero A, Rookus MA, Ross EA, Rossing M, Rudaitis V, Ruebner M, Saloustros E, Sanden K, Santamariña M, Scheuner MT, Schmutzler RK, Schneider M, Scott C, Senter L, Shah M, Sharma P, Shu XO, Simard J, Singer CF, Sohn C, Soucy P, Southey MC, Spinelli JJ, Steele L, Stoppa-Lyonnet D, Tapper WJ, Teixeira MR, Terry MB, Thomassen M, Thompson J, Thull DL, Tischkowitz M, Tollenaar RAEM, Torres D, Troester MA, Truong T, Tung N, Untch M, Vachon CM, van Rensburg EJ, van Veen EM, Vega A, Viel A, Wappenschmidt B, Weitzel JN, Wendt C, Wieme G, Wolk A, Yang XR, Zheng W, Ziogas A, Zorn KK, Dunning AM, Lush M, Wang Q, McGuffog L, Parsons MT, Pharoah PDP, Fostira F, Toland AE, Andrulis IL, Ramus SJ, Swerdlow AJ, Greene MH, Chung WK, Milne RL, Chenevix-Trench G, Dörk T, Schmidt MK, Easton DF, Radice P, Hahnen E, Antoniou AC, Couch FJ, Nevanlinna H, Surrallés J, Peterlongo P. NPJ Breast Cancer. 2019 Nov 1;5:38. doi: 10.1038/s41523-019-0127-5. eCollection 2019.PMID: 31700994
* Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials. Krug D, Lederer B, Seither F, Nekljudova V, Ataseven B, Blohmer JU, Costa SD, Denkert C, Ditsch N, Gerber B, Hanusch C, Heil J, Hilfrich J, Huober JB, Jackisch C, Kümmel S, Paepke S, Schem C, Schneeweiss A, Untch M, Debus J, von Minckwitz G, Kühn T, Loibl S. Ann Surg Oncol. 2019 Nov;26(12):3892-3901. doi: 10.1245/s10434-019-07635-x. Epub 2019 Jul 26.PMID: 31350646 Clinical Trial.